BREAKING! Early Data Shows That BA.2.75.2 And BQ.1.1 Is Causing Varied Strange Symptoms That Are Debilitating In Many That Are Infected!
New clinical observations being reported by doctors in the United Kingdom, Belgium, Germany And Romania are showing that despite BA.2.75.2 and BQ.1.1 not causing the expected disease severity involving ARDS (acute respiratory distress syndrome) or cytokine storms etc, many of the infected are displaying strange debilitating symptoms typically not associated with COVID-19.
Some of these new symptoms include severe gastric reflux, abdominal pains and frequent need to go to the toilets, bone pain, nerve pains, muscle twitches, back pain, chest pain, swellings of some of the key blood vessels, leg swelling and in some cases jaundice ie eyes and skin turning yellow.
Many of these are accompanied by the normal symptoms seen in COVID-19 infections including fever, sore throats, nausea, headaches or severe migraines, cognitive issues including lack of concentration and chronic fatigue.
Physicians and hospitals have reported to Thailand Medical News
that the chest X-rays of many of these infected with the newer strains are showing the same glass -like opacities seen in the early part of the pandemic involving the Wuhan wildtype strain with the exception these patients are not exhibiting hypoxia or ARDS yet.
Another anomaly that physicians are reporting is that in some cases, those infected with new variants do not develop disease severity until about 10 to 18 days after getting infected with the new variants, when secondary lung infections and pneumonia are seen!
It seems that these newer Omicron variants are affecting the CNS system, gastrointestinal system and liver more faster but only affecting the lungs at a slower phase.
Physicians and doctors say it is still too early to make any conclusions but urgent studies are needed to understand the possible changes in tropism and pathogenesis exhibited by these newer Omicron variants.
To date a few deaths have been reported in those infected with the new BA.2.75.2 and BQ.1.1 variants but these were due to heart failures.
Studies are underway by scientist from the United States United Kingdom and China to investigate more about the BA.2.75.2 and BQ.1.1 sub-lineages, the mutations found on them and their possible effects on pathogenesis.
It is already known that both these variants are not only more transmissible but are also more immune evasive that even the last known monoclonal therapeutic- Bebtelovimab is no longer effective against them.
Though both BA.2.75.2 and BQ.1.1 are just only starting to spread in various countries in Europe and also in South-East Asia, they are displaying a huge growth advantage against the other Omicron variants and sub-lineages and are expected to play a very dominant role in the next few weeks globally.
Some researchers are already warning that these newer variants are not only better at causing breakthrough infections irrespective of one’s vaccine status or even of whatever prior SARS-CoV-2 infections one might have had, but they are more adapt at disarming the human host immune responses and capable of causing more cellular, tissue and organ damage in the short term.
Some the implications from these warnings include that we might not see disease severity in the early parts of the infection but down the road, we should see more medical issues and fatal outcomes arising.
For more updates on the BA.2.75.2 and BQ.1.1 sub-lineages
, keep on logging to Thailand Medical News